Topical tacrolimus in atopic dermatitis in children;Tacrolimus tópico en el tratamiento de la dermatitis atópica en niños

Actas Dermo-Sifiliograficas

Volumn 99, Issue SUPPL.2, 2008, Pages 14-18

  Torrelo, A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Atopic dermatitis; Children; Tacrolimus

Indexed keywords

CORTICOSTEROID; PLACEBO; TACROLIMUS;

ATOPIC DERMATITIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; PATIENT CARE; REVIEW; TREATMENT OUTCOME;

EID: 39049141557     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/s0001-7310(08)76206-9     Document Type: Review

References (20)

1. Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, et al; European Working Group on Atopic Dermatitis. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol. 2004;151 Suppl 70:3-27.
2. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ. 2005;330:516.
3. Kyllonen H, Remitz A, Mandelin JM, Elg P, Reitamo S. Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol. 2004;150:1174-81.
4. Furue M, Uchi H, Moroi Y, Ogawa S, Nakahara T, Urabe K. Topical tacrolimus in the management of atopic dermatitis in Japan. Dermatol Ther. 2006;19:118-26.
5. Patel RR, Vander Straten MR, Korman NJ. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. Arch Dermatol. 2003;139:1184-6.
6. Chapman MS, Schachner LA, Breneman D, Boguniewicz M, Gold MH, Shull T, et al; US Tacrolimus Ointment Study Group. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. J Am Acad Dermatol. 2005;53 Suppl: S177-85.
7. Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, et al; US Tacrolimus Ointment Study Group. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Pediatrics. 2005;116:e334-42.
8. Hanifin JM, Paller AS, Eichenfield L, Clark RA, Korman N, Weinstein G, et al; US Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol. 2005;53 Suppl:S186-94.
9. Koo JY, Fleischer AB Jr, Abramovits W, Pariser DM, McCall CO, Horn TD, et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. J Am Acad Dermatol. 2005;53 Suppl:S195-205.
10. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al; ICCAD II Faculty. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003;148 Suppl 63:3-10.
11. Qureshi A, Fischer MA. Topical calcineurin inhibitors revisited. Arch Dermatol. 2007;143:545-6.
12. Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, et al; European Tacrolimus Ointment Group. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol. 2004;150:554-62.
13. Arkwright PD, Gillespie MC, Ewing CI, David TJ. Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis. Clin Exp Dermatol. 2007;32:145-7.
14. Bieber T, Vick K, Folster-Holst R, Belloni-Fortina A, Stadtler G, Worm M, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62:184-9.
15. Paller AS, Lebwohl M, Fleischer AB Jr, Antaya R, Langley RG, Kirsner RS, et al; US/Canada Tacrolimus Ointment Study Group. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005;52:810-22.
16. Hickey JR, Robson A, Barker JN, Smith CH. Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases. Br J Dermatol. 2005;152:152-4.
17. Calza AM, Lubbe J. Tacrolimus ointment-associated alcohol intolerance in infants receiving ethanol-containing medication. Br J Dermatol. 2005;152:569.
18. Stiehm ER, Roberts RL, Kaplan MS, Corren J, Jaracz E, Rico MJ. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment. J Am Acad Dermatol. 2005;53 Suppl:S206-13.
19. Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127:808-16.
20. McNeill AM, Koo JY. Unknown risks of non-steroid topical medications for atopic dermatitis. Int J Dermatol. 2007;46:656-8.